In8bio Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

In8bio Stock Summary

In8bio competes with Reviva Pharmaceuticals, Cue Biopharma, Lantern Pharma, Anixa Biosciences, and INmune Bio. IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. IN8bio, Inc. was incorporated in 2016 and is headquartered in New York, New York. In8Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.

In8bio Key Financial Ratios

In8bio Key Balance Sheet Accounts

In8bio Key Cash Accounts

In8bio Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining In8bio's current stock value. Our valuation model uses many indicators to compare In8bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across In8bio competition to find correlations between indicators driving In8bio's intrinsic value. More Info.In8bio Inc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, In8bio's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the In8bio's earnings, one of the primary drivers of an investment's value.

In8bio Inc Systematic Risk

Today, most investors in In8bio Stock are looking for potential investment opportunities by analyzing not only static indicators but also various In8bio's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of In8bio growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of In8bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of In8bio Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of In8bio Inc based on widely used predictive technical indicators. In general, we focus on analyzing In8bio Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build In8bio's daily price indicators and compare them against related drivers.

When running In8bio's price analysis, check to measure In8bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy In8bio is operating at the current time. Most of In8bio's value examination focuses on studying past and present price action to predict the probability of In8bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move In8bio's price. Additionally, you may evaluate how the addition of In8bio to your portfolios can decrease your overall portfolio volatility.